Q2 2024
|
65 |
47,045 |
WFC-L, AGNC, NLY, ARR
|
13F-HR
|
8/14/2024 |
000095012324008786 |
Q1 2024
|
62 |
46,852 |
WFC-L, AGNC, NLY, ARR
|
13F-HR
|
5/15/2024 |
000095012324005593 |
Q4 2023
|
78 |
129,713 |
WFC-L, IONIS PHARMACEUTICALS INC, EDD, UTMD
|
13F-HR
|
2/13/2024 |
000095012324001877 |
Q3 2023
|
69 |
106,636 |
WFC-L, PKE, FF, BCX
|
13F-HR
|
11/13/2023 |
000095012323010177 |
Q2 2023
|
69 |
110,907 |
WFC-L, EDD, BCX, EPM
|
13F-HR
|
8/11/2023 |
000095012323007487 |
Q1 2023
|
63 |
105,389 |
FBRT, WFC-L, BCX, EDD
|
13F-HR
|
5/5/2023 |
000095012323003836 |
Q4 2022
|
61 |
89,579 |
WFC-L, BCX, FBRT, EDD
|
13F-HR
|
2/13/2023 |
000095012323001616 |
Q3 2022
|
64 |
76,420 |
WFC-L, BCX, FBRT, EDD
|
13F-HR
|
11/14/2022 |
000095012322012041 |
Q2 2022
|
54 |
74,191 |
FBRT, BCX, FAX, EDD
|
13F-HR
|
8/11/2022 |
000095012322008385 |
Q1 2022
|
54 |
86,227 |
FBRT, BCX, FAX, EDD
|
13F-HR
|
5/12/2022 |
000095012322005306 |
Q4 2021
|
56 |
93,317 |
FBRT, WFC-L, FAX, FORTIVE CORP
|
13F-HR
|
2/14/2022 |
000095012322002809 |
Q3 2021
|
73 |
63,235 |
RITM, FORTIVE CORP, EDD, SPG
|
13F-HR
|
11/4/2021 |
000095012321013945 |
Q2 2021
|
87 |
80,009 |
EMLC, EDD, FORTIVE CORPORATION 0.875 02/15/2022, EMD
|
13F-HR
|
8/26/2021 |
000095012321011883 |
Q1 2021
|
82 |
88,516 |
EMLC, NLY, EDD, RITM
|
13F-HR
|
5/13/2021 |
000095012321006254 |
Q4 2020
|
75 |
113,189 |
NLY, EMLC, FAX, AGNC
|
13F-HR
|
2/9/2021 |
000095012321001303 |
Q3 2020
|
50 |
70,872 |
EMLC, AGNC, AIMT, FORTIVE CORP
|
13F-HR
|
11/10/2020 |
000095012320011199 |
Q2 2020
|
30 |
97,848 |
EMLC, FAX, AGNC, WFC-L
|
13F-HR
|
8/3/2020 |
000095012320007509 |
Q1 2020
|
30 |
137,880 |
EMLC, NLY, AGNC, PFF
|
13F-HR
|
5/14/2020 |
000095012320004890 |
Q4 2019
|
30 |
124,192 |
EMLC, AGNC, NLY, FAX
|
13F-HR
|
2/13/2020 |
000095012320001793 |
Q3 2019
|
23 |
148,250 |
EMLC, AGNC, NLY, RITM
|
13F-HR
|
11/7/2019 |
000095012319010251 |
Q2 2019
|
22 |
101,378 |
AGNC, NLY, FAX, T
|
13F-HR
|
8/14/2019 |
000095012319008206 |
Q1 2019
|
21 |
8,728 |
FAX, EDD, AGNC, NLY
|
13F-HR
|
5/13/2019 |
000095012319004552 |
Q4 2018
|
20 |
73,118 |
AGNC, FAX, EDD, NLY
|
13F-HR
|
1/31/2019 |
000095012319000502 |
Q3 2018
|
21 |
107,701 |
AGNC, NLY, FAX, EDD
|
13F-HR
|
11/9/2018 |
000095012318010936 |